Susceptibility markers in colorectal cancer.
Many susceptibility factors contribute to an individual's risk of developing colorectal cancer. Family history of colorectal cancer (particularly with early age of onset), maleness and increasing age are all factors associated with increasing risk. About three quarters of colorectal cancers are thought to be due to somatic mutations, and both high- and low-penetrance predisposing genes contribute to the remaining quarter of cases. Many of the highly penetrant dominant genes are known, but others remain to be identified. Describing the contribution of individual genes is likely to be very complex, as some modify the impact of other genes and other environmental factors rather than incurring a direct, easily attributable effect. The two dominant predisposing syndromes are familial adenomatous polyposis and Lynch syndrome, the first due to a mutant tumour-suppressor gene APC, and the second due to mutations in a number of genes responsible for mismatch repair in DNA at cell division. Establishing genetic susceptibility for colorectal cancer will soon be possible, and could save lives by allowing targetting of screening and the encouragement of preventive behaviours. However, there will always be a risk of making healthy people "sick" through the identification of predisposing genes, and there are many potential ways by which a gene carrier may be stigmatized by society, insurance companies and employers.
Burn
J
J
School of Biochemistry and Genetics, University of Newcastle, Newcastle upon Tyne, UK.
Chapman
P D
PD
Bishop
D T
DT
Smalley
S
S
Mickleburgh
I
I
West
S
S
Mathers
J C
JC
D000368:Aged; D000818:Animals; D014408:Biomarkers, Tumor / Q000235:genetics*; D015179:Colorectal Neoplasms / Q000235:genetics* / Q000517:prevention & control; D004195:Disease Models, Animal; D005820:Genetic Testing; D006801:Humans; D008297:Male; D051379:Mice; D008875:Middle Aged; D009386:Neoplastic Syndromes, Hereditary / Q000175:diagnosis / Q000235:genetics; D011110:Polymorphism, Genetic; D012306:Risk
D014408:Biomarkers, Tumor